Aptera Motors Secures $5.96M Through Warrant Inducement, Adds 4.32M New Warrants

summarizeSummary

Aptera Motors raised $5.96 million through a warrant inducement, issuing 4.32 million new warrants at $2.25. The cash infusion supports operations amid a going concern warning, but the new warrants create significant dilution risk.

check_boxKey Events · Financing and Capital Events · SEV

• Warrant Inducement Raises $5.96M

  Holders exercised 2.88 million existing warrants at a reduced price of $2.07 per share, generating $5.96 million in gross proceeds before fees.

• 4.32M New Warrants Issued

  As consideration, the company issued 4.32 million new warrants with a $2.25 exercise price, exercisable from January 13, 2027, and expiring January 13, 2032 — representing potential dilution of approximately 11.5% of outstanding shares.

• Use of Proceeds for Operations

  Net proceeds will fund working capital, general corporate purposes, and continued validation vehicle manufacturing and testing, addressing near-term cash needs highlighted by the going concern warning.

• Registration and Lock-Up Commitments

  The company must file a resale registration statement for the new warrant shares by August 12, 2026, and is subject to a lock-up restricting further equity issuances until that date.

auto_awesomeAnalysis · SEV · Manufacturing

Aptera Motors closed a warrant inducement deal, raising $5.96 million by having holders exercise 2.88 million existing warrants at a reduced $2.07 per share. In exchange, the company issued 4.32 million new warrants with a $2.25 strike, exercisable in six months. The transaction provides near-term cash to fund operations and validation vehicle testing, but the new warrants represent significant potential dilution — roughly 11.5% of the current outstanding shares if fully exercised. The deal also includes a lock-up on further equity issuances until August 12, 2026, and a commitment to register the new warrant shares for resale. Against a backdrop of a going concern warning and a $10.2 million Q1 net loss, this capital injection is critical for extending the runway, though the dilutive overhang and the discounted exercise price relative to the current $1.86 stock price signal investor caution.